Literature DB >> 23966564

Counterpoint: cervical cancer screening guidelines--approaching the golden age.

Sandra D Isidean, Eduardo L Franco.   

Abstract

Changes in screening guidelines that imply suppression of procedures once recommended are always controversial because of the perception that benefits are being curtailed. Prior to 2012, cervical cancer screening guidelines issued by US-based expert bodies differed in several decision areas, making clinicians essentially cherry-pick among recommendations. To some extent, this approach to screening practices also served to shield clinicians from litigation. It implied starting screening earlier, doing it more frequently, and stopping later in life than necessary. This state of affairs changed in 2012, when the most influential professional groups updated their cervical screening guidelines, and recommendations became essentially unified. All groups recommended that women older than 65 years of age discontinue cervical cancer screening on the basis of evidence that screening benefits in this age group were minor and far outweighed by harms. The guidelines are very specific about the exceptions, which ensure acceptable safety. It is expected that the new guidelines will permit less wasteful cervical screening, while fostering the opportunity to direct resources towards ensuring adequate coverage of high-risk women.

Entities:  

Keywords:  Papanicolaou smear; cervical cancer; human papillomavirus; screening; women's health

Mesh:

Year:  2013        PMID: 23966564     DOI: 10.1093/aje/kwt171

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  5 in total

1.  Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.

Authors:  Alejandra Castañón; Rebecca Landy; Jack Cuzick; Peter Sasieni
Journal:  PLoS Med       Date:  2014-01-14       Impact factor: 11.069

2.  Cervical cancer screening in older women: new evidence and knowledge gaps.

Authors:  Anne F Rositch; Michelle I Silver; Patti E Gravitt
Journal:  PLoS Med       Date:  2014-01-14       Impact factor: 11.069

3.  Automated recommendation for cervical cancer screening and surveillance.

Authors:  Kavishwar B Wagholikar; Kathy L MacLaughlin; Petra M Casey; Thomas M Kastner; Michael R Henry; Ronald A Hankey; Steve G Peters; Robert A Greenes; Christopher G Chute; Hongfang Liu; Rajeev Chaudhry
Journal:  Cancer Inform       Date:  2014-10-15

4.  Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.

Authors:  Rebecca Landy; Mark Schiffman; Peter D Sasieni; Li C Cheung; Hormuzd A Katki; Greg Rydzak; Nicolas Wentzensen; Nancy E Poitras; Thomas Lorey; Walter K Kinney; Philip E Castle
Journal:  Int J Cancer       Date:  2019-04-08       Impact factor: 7.396

5.  Expanding the upper age limit for cervical cancer screening: a protocol for a nationwide non-randomised intervention study.

Authors:  Mette Tranberg; Lone Kjeld Petersen; Klara Miriam Elfström; Anne Hammer; Jan Blaakær; Mary Holten Bennetsen; Jørgen Skov Jensen; Berit Andersen
Journal:  BMJ Open       Date:  2020-11-05       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.